Daniella Beckman Tango Therapeutics, Inc. (TNGX) insider trading activity

Daniella Beckman is Chief Financial Officer of Tango Therapeutics, Inc.. Currently has a direct ownership of 150,284 shares of TNGX, which is worth approximately $503,451. The most recent transaction as insider was on Feb 05, 2025, when has been sold 3,948 shares (Common Stock) at a price of $3.16 per share, resulting in proceeds of $12,475. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K

13.51% 3M change

13.51% 12M change

Total Value Held $503,451

Daniella Beckman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 05 2025	SELL Open market or private sale	$12,475 $3.16 p/Share	3,948 Reduced 2.56%	150,284 Common Stock
Feb 04 2025	SELL Open market or private sale	$12,809 $2.99 p/Share	4,284 Reduced 2.7%	154,232 Common Stock
Feb 03 2025	BUY Grant, award, or other acquisition	-	26,119 Added 14.15%	158,516 Common Stock
Feb 07 2024	SELL Open market or private sale	$22,930 $12.62 p/Share	1,817 Reduced 1.35%	132,397 Common Stock
Feb 06 2024	SELL Open market or private sale	$23,964 $12.56 p/Share	1,908 Reduced 1.4%	134,214 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	39,413 Added 50.0%	39,413 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	32,842 Added 25.35%	96,709 Common Stock

Also insider at

FVAM

5:01 Acquisition Corp. Financial Services

Director

VOR

Vor Biopharma Inc. Healthcare

TBIO

Translate Bio, Inc. Healthcare

Director

BPMC

Blueprint Medicines Corp Healthcare

UPB

Upstream Bio, Inc.